// App-Quantinova.ai

4663 : Results of telomerase activity measurements from live circulating tumor cells captured on a slot microfilter in a phase III SWOG-coordinated prostate cancer trial (S0421).

Researchers

Presenter

  • Amir Goldkorn

Principal Investigators

  • Benjamin Ely

  • David I. Quinn

  • Philip C. Mack

  • Primo Lara

  • Celestia S. Higano

  • Maha Hussain

  • Nicholas J. Vogelzang

  • Richard J Cote

  • Ian Murchie Thompson

  • Catherine M. Tangen

  • Yu-Chong Tai

  • Przemyslaw Twardowski

  • Peter J. Van Veldhuizen

  • Neeraj Agarwal

  • Michael Anthony Carducci

  • J. P. Monk

  • Mark Garzotto

Medical Centers

  • The Ohio State Univerisity, Columbus, OH

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • SWOG Statistical Center, Seattle, WA

  • City of Hope, Duarte, CA

  • University of California, San Francisco, CA

  • University of Miami Miller School of Medicine, Miami, FL

  • California Institute of Technology, Pasadena, CA.

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Portland Veterans Affairs Medical Center, Portland, OR

  • University of Kansas Medical Center, Westwood, KS

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A